Mucormycosis in a case of multisystem inflammatory syndrome in children: "double trouble" (case report)

Keta Vagha1, Revat Meshram1, Sham Lohiya1

  • 1Department of Pediatrics, Jawaharlal Nehru Medical College, Sawangi (Meghe), Wardha, Maharashtra, India.

Insights

Multisystem inflammatory syndrome in children (MIS-C) is linked to mucormycosis, a severe fungal infection. This case highlights the risk of mucormycosis in pediatric MIS-C patients, emphasizing the need for early diagnosis and intervention.

Area of Science:

  • Pediatric Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with COVID-19.
  • Mucormycosis, a fungal infection, poses a high mortality risk, particularly in immunocompromised individuals.
  • While mucormycosis is documented in COVID-19 patients, its occurrence in MIS-C is less understood.

Observation:

  • A nine-year-old girl diagnosed with MIS-C presented with fever, eye redness, and swelling.
  • She developed end-organ damage, including oliguria and liver dysfunction, during prolonged hospitalization.
  • The patient subsequently developed a nasal lesion, confirmed as mucormycosis via histopathology.

Findings:

  • The case demonstrates a fatal instance of mucormycosis in a pediatric patient with MIS-C.
  • Histopathology confirmed mucormycosis, a severe fungal infection, in the nasal lesion.
  • Despite medical intervention, the patient succumbed to multiple organ dysfunction.

Implications:

  • This case suggests a potential association between MIS-C and the development of mucormycosis.
  • Limited data exists on mucormycosis in MIS-C, underscoring the need for further research.
  • Early recognition and prompt treatment of mucormycosis in MIS-C patients are crucial for improving outcomes.